Compounds found in cannabis could provide a new roadmap for treating the world’s most common chronic liver disorder, according to a study released by the Hebrew University of Jerusalem.

Two non-intoxicating cannabis compounds, cannabidiol (CBD) and cannabigerol (CBG), reduced key markers of fatty liver disease in obese mice after just four weeks of daily treatment, according to a ...

Rockville, May 25, 2023 (GLOBE NEWSWIRE) -- As per Fact.MR, a provider of market research and competitive intelligence, the global cannabigerol market is expected to reach US$ 60.84 billion by the end ...

For more information about this report visit https://www.researchandmarkets.com/r/1laatj ...

Cannabigerol (CBG) has significant potential to treat neurological disorders according to a recent study published in Pharmaceuticals. The Penn State research team determined that CBG can be a ...

Cannabigerol, an extract found naturally in the cannabis plant, is an increasingly popular treatment (as over-the-counter CBG oil) for chronic pain and inflammation. However, repeated use of ...

In a recent study published in Scientific Reports, researchers conducted a placebo-controlled, double-blind crossover field trial to examine whether the phytocannabinoid cannabigerol impacted mood, ...

CBG (Cannabigerol) was first discovered in the 1960s and is the originator from which all cannabinoids were created. This exclusive remedy is promised to provide enormous therapeutic results. This ...